Key papers in Psychiatry and Mental health
Pofolia’s corpus holds 81 papers from the Psychiatry and Mental health subfield (1999–2026). The list below starts with the most cited.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”.
The Effect of Riding as an Alternative Treatment for Children with Cerebral Palsy: A Systematic Review and Meta-Analysis
Integrative Medicine International · 2015 · FWCI 176.39 · 18,699 citations · Open access
Hippotherapy, therapeutic horse riding, and artificial saddle use significantly improve gross motor function in children with cerebral palsy, particularly in walking, running, and jumping.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet · 2017 · FWCI 1019.99 · 13,573 citations · Open access
Globally, the total number of years lived with disability (YLDs) decreased by 2.7% from 1990-2016, but the absolute number of YLDs from non-communicable diseases is rapidly increasing due to aging populations. Low back pain, migraine, and hearing loss were the leading causes of YLDs in 2016.
Pharmacological interventions for somatoform disorders in adults
Cochrane Database of Systematic Reviews · 2014 · FWCI 476.92 · 11,360 citations
This systematic review found very low-quality evidence that new-generation antidepressants (NGAs) may reduce the severity of medically unexplained physical symptoms (MUPS) in adults with somatoform disorders. Low-quality evidence also suggests natural products may be effective.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Cephalalgia · 2018 · Q1 · SJR 1.00 · FWCI 552.95 · 10,592 citations · Open access
The International Headache Society (IHS) has released the 3rd edition of the International Classification of Headache Disorders (ICHD-3). This updated classification system provides a standardized framework for diagnosing and categorizing headache disorders.
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Alzheimer s & Dementia · 2018 · Q1 · SJR 4.00 · FWCI 497.34 · 10,499 citations · Open access
A new research framework defines Alzheimer's disease (AD) by its underlying pathology, using biomarkers like amyloid and tau (ATN), rather than clinical symptoms.
Mild Cognitive Impairment
Archives of Neurology · 1999 · FWCI 51.80 · 9,031 citations
Subjects with Mild Cognitive Impairment (MCI) show memory deficits beyond age expectations but are not demented, distinguishing them from healthy controls and mild Alzheimer's Disease (AD) patients.
The International Classification of Headache Disorders, 3rd edition (beta version)
Cephalalgia · 2013 · Q1 · SJR 1.00 · FWCI 405.71 · 8,241 citations · Open access
This paper presents the beta version of the 3rd edition of the International Classification of Headache Disorders (ICHD-3 beta). It serves as a preliminary update to the diagnostic criteria for headache disorders.
ILAE Official Report: A practical clinical definition of epilepsy
Epilepsia · 2014 · Q1 · SJR 2.00 · FWCI 153.14 · 5,953 citations
The International League Against Epilepsy (ILAE) has updated the practical definition of epilepsy to include individuals with one unprovoked seizure and a high recurrence risk (>=60% over 10 years), or a diagnosed epilepsy syndrome.
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
The Lancet Public Health · 2022 · Q1 · SJR 8.00 · FWCI 617.78 · 5,239 citations · Open access
The global number of dementia cases is projected to nearly triple from 57.4 million in 2019 to 152.8 million by 2050, driven primarily by population growth and aging.
2016 Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2016 · Q1 · SJR 4.00 · FWCI 551.02 · 5,109 citations
Alzheimer's disease is a growing public health crisis, with an estimated 5.4 million Americans currently affected and projected to reach 13.8 million by mid-century. Deaths from Alzheimer's increased 71% between 2000 and 2013, contrasting with decreases in deaths from other major diseases.
The global prevalence of dementia: A systematic review and metaanalysis
Alzheimer s & Dementia · 2013 · Q1 · SJR 4.00 · FWCI 48.22 · 4,933 citations
Globally, 35.6 million people lived with dementia in 2010, with prevalence ranging from 5-7% in most regions, but notably lower in sub-Saharan Africa (2-4%) and higher in Latin America (8.5%).
<scp>ILAE</scp> classification of the epilepsies: Position paper of the <scp>ILAE</scp> Commission for Classification and Terminology
Epilepsia · 2017 · Q1 · SJR 2.00 · FWCI 227.71 · 4,917 citations · Open access
The International League Against Epilepsy (ILAE) has released an updated classification system for epilepsies, reflecting recent scientific advances and incorporating etiology at each diagnostic level.
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
New England Journal of Medicine · 2012 · Q1 · SJR 18.00 · FWCI 131.51 · 3,848 citations
In autosomal dominant Alzheimer's disease, key pathological changes begin decades before symptom onset, with amyloid-beta levels dropping 25 years prior and brain metabolism impairment appearing 10 years before.
Interplay between Cortical Spreading Depolarization and Seizures
Stereotactic and Functional Neurosurgery · 2017 · Q2 · FWCI 164.05 · 3,708 citations · Open access
This paper clarifies the complex, bidirectional relationship between cortical spreading depolarization (CSD) and seizures, suggesting CSD may synchronize brain tissue, potentially favoring seizure activity.
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
Molecular Psychiatry · 2021 · Q1 · SJR 4.00 · FWCI 120.54 · 3,665 citations · Open access
Globally, 62.5% of individuals experience the onset of any mental disorder by age 25, with a peak onset age of 14.5 years, according to a meta-analysis of 192 studies involving over 700,000 people.
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
Dementia and Geriatric Cognitive Disorders Extra · 2013 · Q3 · FWCI 134.85 · 3,465 citations · Open access
A newly developed Geriatric Depression Scale (GDS) demonstrates strong reliability and validity for assessing depression in the elderly, outperforming the Zung Self-Rating Depression Scale (SDS).
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology
Epilepsia · 2017 · Q1 · SJR 2.00 · FWCI 170.66 · 3,399 citations · Open access
The International League Against Epilepsy (ILAE) has released a revised operational classification for seizure types, introducing more transparent terminology and allowing for classification when seizure onset is unobserved.
2013 Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2013 · Q1 · SJR 4.00 · FWCI 204.50 · 3,337 citations
Alzheimer's disease (AD) is a growing public health crisis, with an estimated 5.2 million Americans currently affected and a new case developing every 68 seconds. The proportion of deaths from AD increased by 68% between 2000 and 2010, significantly outpacing declines in deaths from heart disease, stroke, and prostate cancer.
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Alzheimer s & Dementia · 2012 · Q1 · SJR 4.00 · FWCI 77.84 · 3,192 citations · Open access
Updated guidelines for neuropathologic assessment of Alzheimer's disease (AD) now incorporate amyloid accumulation alongside neurofibrillary changes and neuritic plaques, and recognize a pre-clinical stage of AD.
2023 Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2023 · Q1 · SJR 4.00 · FWCI 572.32 · 3,143 citations
Alzheimer's disease is a growing public health crisis, with an estimated 6.7 million Americans currently affected and projected to reach 13.8 million by 2060 without breakthroughs. Deaths from Alzheimer's increased over 145% between 2000 and 2019, and the disease remains a leading cause of death.
Recently added
Quantenmonaden XVII – Gehirn, Bewusstsein und relationale Kohärenz: Ein neuer Zugang zu Demenz und Alzheimer
Zenodo (CERN European Organization for Nuclear Research) · 2026
A new neurological and consciousness-theoretic model, based on Quantum Monads 1.0, proposes relational coherence and non-separability as a formalizable, empirically testable structure that may persist or be reactivated despite cognitive decline in dementia and Alzheimer's.
Motor developmental Tui na method with comprehensive rehabilitation in children with spastic cerebral palsy: A randomized controlled trial
Complementary Therapies in Medicine · 2026 · Q1
Combining Tui Na motor developmental therapy with standard rehabilitation significantly improved active ankle range of motion and reduced gastrocnemius muscle strain in children with spastic cerebral palsy compared to standard rehabilitation alone.
The relationship between triceps surae muscle–tendon morphology and shear modulus across passive ankle range of motion in cerebral palsy
Journal of Biomechanics · 2025 · Q1 · FWCI 4.06 · 5 citations
Individuals with cerebral palsy (CP) exhibit significantly higher passive muscle stiffness in the medial (26.8 kPa vs 19.7 kPa) and lateral gastrocnemius (20.2 kPa vs 14.1 kPa) compared to typically developing peers, with this difference remaining consistent across ankle range of motion.
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Alzheimer s & Dementia · 2024 · Q1 · SJR 4.00 · FWCI 682.61 · 2,339 citations · Open access
Alzheimer's disease (AD) is now defined as a biological process starting with asymptomatic neuropathologic changes (ADNPC), diagnosed by abnormal Core 1 biomarkers (amyloid PET, CSF, or plasma p-tau217), which is sufficient for diagnosis and clinical decision-making.
2024 Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2024 · Q1 · SJR 4.00 · FWCI 651.08 · 2,262 citations · Open access
Alzheimer's disease (AD) is projected to affect 13.8 million Americans by 2060, with reported deaths increasing over 140% between 2000-2021, making it the seventh-leading cause of death in the US in 2020-2021.
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app